Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corey J Langer

Showing results (71-80 of 225) with videos related to

Pageof 23
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastasesMark A Socinski, Corey J Langer, Jane E Huang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2019
Comparative Effectiveness of Carboplatin/Pemetrexed With Versus Without Bevacizumab for Advanced Nonsquamous Non-Small Cell Lung CancerStephen J Bagley, Suzanna Talento, Nandita Mitra, et al.
Clinical Lung Cancer|July 30, 2014
Strategies to prevent brain metastasis in high-risk non-small-cell lung cancer: lessons learned from a randomized study of maintenance temozolomide versus observationD Hunter Boggs, H Ian Robins, Corey J Langer, et al.
Journal of Oncology Practice|January 2, 2013
Cost effectiveness of personalized therapy for first-line treatment of stage IV and recurrent incurable adenocarcinoma of the lungElizabeth A Handorf, Sean McElligott, Anil Vachani, et al.
Chest|October 6, 2007
Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines (2nd edition)Mark A Socinski, Richard Crowell, Thomas E Hensing, et al.
Future Oncology (London, England)|August 1, 2019
Patient-reported outcomes and quality of life in advanced ALK+ non-small-cell lung cancer trial of brigatinib (ALTA)William R Lenderking, Huamao Lin, Rebecca M Speck, et al.
Integrative Cancer Therapies|April 27, 2016
Acupuncture for Dyspnea in Lung Cancer: Results of a Feasibility TrialJoshua Bauml, Andrew Haas, Charles B Simone, et al.
Tumori|November 10, 2005
P53 alteration in oral tongue cancer is not significantly associated with age at diagnosis or tobacco exposureNava Siegelmann-Danieli, Ofer Ben-Izhack, Alexandra Hanlon, et al.
The Annals of Thoracic Surgery|March 31, 2005
The surgical management of superior sulcus tumors: a retrospective review with long-term follow-upMelvyn Goldberg, Dipin Gupta, Aaron R Sasson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 14, 2011
Hematologic outcomes and blood utilization in cancer patients with chemotherapy-induced anemia (CIA) pre- and post-national coverage determination (NCD): results from a multicenter chart reviewDavid H Henry, Corey J Langer, R Scott McKenzie, et al.
Pageof 23

Showing results (71-80 of 225) with videos related to

Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastasesMark A Socinski, Corey J Langer, Jane E Huang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2019
Comparative Effectiveness of Carboplatin/Pemetrexed With Versus Without Bevacizumab for Advanced Nonsquamous Non-Small Cell Lung CancerStephen J Bagley, Suzanna Talento, Nandita Mitra, et al.
Clinical Lung Cancer|July 30, 2014
Strategies to prevent brain metastasis in high-risk non-small-cell lung cancer: lessons learned from a randomized study of maintenance temozolomide versus observationD Hunter Boggs, H Ian Robins, Corey J Langer, et al.
Journal of Oncology Practice|January 2, 2013
Cost effectiveness of personalized therapy for first-line treatment of stage IV and recurrent incurable adenocarcinoma of the lungElizabeth A Handorf, Sean McElligott, Anil Vachani, et al.
Chest|October 6, 2007
Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines (2nd edition)Mark A Socinski, Richard Crowell, Thomas E Hensing, et al.
Future Oncology (London, England)|August 1, 2019
Patient-reported outcomes and quality of life in advanced ALK+ non-small-cell lung cancer trial of brigatinib (ALTA)William R Lenderking, Huamao Lin, Rebecca M Speck, et al.
Integrative Cancer Therapies|April 27, 2016
Acupuncture for Dyspnea in Lung Cancer: Results of a Feasibility TrialJoshua Bauml, Andrew Haas, Charles B Simone, et al.
Tumori|November 10, 2005
P53 alteration in oral tongue cancer is not significantly associated with age at diagnosis or tobacco exposureNava Siegelmann-Danieli, Ofer Ben-Izhack, Alexandra Hanlon, et al.
The Annals of Thoracic Surgery|March 31, 2005
The surgical management of superior sulcus tumors: a retrospective review with long-term follow-upMelvyn Goldberg, Dipin Gupta, Aaron R Sasson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 14, 2011
Hematologic outcomes and blood utilization in cancer patients with chemotherapy-induced anemia (CIA) pre- and post-national coverage determination (NCD): results from a multicenter chart reviewDavid H Henry, Corey J Langer, R Scott McKenzie, et al.
Pageof 23